Clinical Trial Update: VenaTech Convertible Vena Cava Filter U.S. Multi-Center Clinical Trial [NA]

View source ↗

Summary

The U.S. multi-center trial of the VenaTech Convertible Vena Cava Filter for preventing pulmonary embolism has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Drugs mentioned

• VenaTech Convertible Vena Cava Filter

Snippet

Sponsor: B. Braun Interventional Systems, Inc | Conditions: Pulmonary Embolism | NA | Status: COMPLETED | Results posted: 2016-07-11